Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1963 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1963 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Oncology
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
What is being tested: Odronextamab (an experimental bispecific antibody) combined with chemotherapy versus the standard rituximab-chemotherapy regimen in treatment-naïve adult patients with diffuse large…
08 Jul 2026 NCT06091865
● Recruiting Phase I Oncology
Safety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
What is being tested: Ponatinib, a tyrosine kinase inhibitor, is being evaluated for safety, tolerability, pharmacokinetics, and efficacy in paediatric patients aged 1-18 years…
08 Jul 2026 NCT03934372
● Recruiting Phase III
A Study of Brenipatide in Participants With Alcohol Use Disorder
Brenipatide tested against placebo over 56 weeks to assess whether it safely reduces alcohol use in people with alcohol use disorder.
07 Jul 2026 NCT07219953
active not recruiting Phase III Oncology
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer
Durvalumab added to standard BCG therapy improved outcomes compared to BCG alone in non-muscle-invasive bladder cancer.
07 Jul 2026 NCT03528694
active not recruiting Phase III
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous Emicizumab in Participants From Birth to 12 Months of Age With Hemophilia A Without Inhibitors
Emicizumab injections prevent bleeding in babies under 12 months with severe haemophilia A, with safety and effectiveness monitored over 8 years.
07 Jul 2026 NCT04431726
● Recruiting Phase III Diabetes / Metabolic
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
A trial testing whether eloralintide injection reduces knee osteoarthritis pain in overweight or obese adults over 75 weeks.
07 Jul 2026 NCT07353931
active not recruiting Oncology
A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical Practice
Real-world study observing outcomes in advanced prostate cancer patients treated with darolutamide plus hormone therapy, with or without chemotherapy.
07 Jul 2026 NCT07344779
● Recruiting
The Rhabdomyolysis Evaluation in the Emergency Department (REED) Score
What is being tested: The REED Score is a clinical tool designed to identify adults over 65 who have experienced a long lie (remaining…
07 Jul 2026 NCT07158554
● Recruiting Cardiology / Cardiovascular
Sixth Generation High-sensitivity Cardiac Troponin T for the Early Rule Out of Myocardial Infarction: a Controlled Before and After Study
What is being tested: A sixth-generation high-sensitivity cardiac troponin T assay evaluated in a controlled before-and-after study design to determine its ability to safely…
07 Jul 2026 NCT07636642
● Recruiting Oncology
RESCUE: A Workplace Dietary Intervention for UK Firefighters
What is being tested: A workplace dietary intervention programme designed to improve nutritional habits and food choices among UK firefighters, addressing the specific challenges…
07 Jul 2026 NCT07687849
active not recruiting Phase I / Phase II
A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma
New dual-targeted CAR-T cell therapy tested in relapsed/refractory B-cell lymphoma and high-risk newly diagnosed DLBCL.
06 Jul 2026 NCT05421663
active not recruiting Phase I Oncology
Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer
Trial testing new cancer drug amivantamab alone and combined with existing treatments in advanced lung cancer patients to find safe, effective doses.
06 Jul 2026 NCT02609776
● Recruiting Phase III Gastroenterology
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn’s Disease
This trial tests a new drug called Afimkibart to treat moderate-to-severe Crohn's disease, comparing it against placebo.
06 Jul 2026 NCT06819891
active not recruiting Phase I Oncology
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer
This study tested whether a new prostate cancer drug (ARN-509) can be safely combined with abiraterone acetate, and whether dose adjustments are needed.
06 Jul 2026 NCT02123758
active not recruiting Phase I Oncology
A Study of Teclistamab With Other Anticancer Therapies in Participants With Multiple Myeloma
Trial testing whether teclistamab combined with other cancer drugs is safe and effective for multiple myeloma patients.
06 Jul 2026 NCT04722146
active not recruiting Phase I / Phase II Oncology
An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin’s Lymphoma
Testing two new drug combinations with glofitamab in patients with relapsed/refractory B-cell lymphoma to find safe doses and assess effectiveness.
06 Jul 2026 NCT03533283
● Recruiting Phase II / Phase III
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
A trial testing whether a new drug (atumelnant) safely and effectively treats congenital adrenal hyperplasia in children.
06 Jul 2026 NCT07159841
● Recruiting
AI Timing in Chest X-ray Interpretation Using Eye-Tracking
Study tests whether showing AI analysis before or after clinicians initially review chest X-rays affects their interpretation decisions and AI trust.
06 Jul 2026 NCT07675694
● Recruiting Phase III
A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism
Baxdrostat reduced blood pressure and normalised hormone levels better than placebo in primary aldosteronism patients.
06 Jul 2026 NCT07007793
active not recruiting Phase III Oncology
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAS
Apalutamide combined with hormone therapy improved metastasis-free survival in high-risk prostate cancer patients receiving radiotherapy.
06 Jul 2026 NCT02531516
● Recruiting Phase III Rheumatology
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA)
Trial testing whether baricitinib is safe and effective for treating systemic juvenile idiopathic arthritis in children aged 1-18 years.
06 Jul 2026 NCT04088396
● Recruiting Phase II
Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I)
Infliximab did not improve outcomes in acute pancreatitis compared to placebo in this randomised controlled trial.
06 Jul 2026 NCT03684278
active not recruiting
Global Patient Registry of Inherited Retinal Diseases
This registry collects data on inherited retinal disease patients worldwide to understand disease progression and improve how doctors manage these conditions.
06 Jul 2026 NCT05957276
● Recruiting Respiratory / COPD / Asthma
A Trial Evaluating Novel Technologies for the Diagnosis of Asthma The LUNG-TECH Trial
Novel diagnostic technologies are being evaluated across three pathways to determine their clinical utility in asthma diagnosis, including their ability to differentiate asthma from…
06 Jul 2026 NCT05819944
● Recruiting Mental Health / Psychiatry
INCLUDE-CKD: INCLUsive Digital carE for Chronic Kidney Disease
What is being tested: MyRenalCare, a digital health app designed to support management and self-care in chronic kidney disease (CKD) patients, with evaluation of…
06 Jul 2026 NCT07613593
● Recruiting Cardiology / Cardiovascular
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation – APOLLO-EU Trial
Intervention being tested: Safety and efficacy of Medtronic Intrepid™ Transcatheter Mitral Valve Replacement (TMVR) system as a transfemoral approach in patients with significant mitral…
06 Jul 2026 NCT05496998
● Recruiting Phase III Cardiology / Cardiovascular
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
What is being tested: JNJ-79635322 is being directly compared with a BCMA×CD3 bispecific antibody—both novel immunotherapies designed to engage T cells against BCMA-expressing myeloma…
06 Jul 2026 NCT07258511
● Recruiting
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
A pilot study comparing gum surgery alone versus surgery combined with a special gel to treat deep gum defects.
02 Jul 2026 NCT06309719
active not recruiting Phase I / Phase II Gastroenterology
Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients
QEL-001 Trial Summary A study testing a personalised cell therapy to help liver transplant patients accept their donor organ without long-term immunosuppression.
02 Jul 2026 NCT05234190
active not recruiting Phase II Oncology
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.
JDQ443 alone as initial treatment for advanced lung cancer with KRAS G12C mutation and low immune marker or specific genetic features.
02 Jul 2026 NCT05445843
active not recruiting Phase III
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Trial comparing iberdomide versus lenalidomide as maintenance therapy after stem cell transplant in newly diagnosed myeloma patients.
02 Jul 2026 NCT05827016
active not recruiting Phase III Infectious Disease
A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy
Two-drug HIV treatment works as well as three-drug treatment, with simpler dosing and fewer side effects in treatment-naive adults.
02 Jul 2026 NCT05979311
● Recruiting Phase III Oncology
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Treatment being tested: Trastuzumab deruxtecan (T-DXd) combined with pembrolizumab compared to platinum-based chemotherapy with pembrolizumab as first-line therapy for HER2-overexpressing advanced non-squamous non-small cell…
02 Jul 2026 NCT06899126
● Recruiting Phase II Respiratory / COPD / Asthma
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
What is being tested: GSK3862995B, a novel investigational drug, is being evaluated for its effectiveness and safety in treating bronchiectasis, alongside assessment of pharmacokinetics…
02 Jul 2026 NCT07201051
● Recruiting Cardiology / Cardiovascular
A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta
What is being tested: The Rapidlink device is being evaluated for safety and effectiveness as an aid in open surgical repair of thoracic aortic…
02 Jul 2026 NCT07078383
● Recruiting Phase III Cardiology / Cardiovascular
Thromboprophylaxis in Lower Limb Immobilisation
What is being tested: The clinical and cost effectiveness of thromboprophylaxis (blood clot prevention) in patients immobilised with plaster casts or splints following injury,…
02 Jul 2026 NCT06370273
● Recruiting Phase II Oncology
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton’s Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
NX-5948, a novel protein degradation agent, is being tested as a potential treatment for patients with relapsed/refractory CLL/SLL who have exhausted standard therapeutic options…
02 Jul 2026 NCT07221500
● Recruiting Phase III
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Trial testing whether atogepant tablets safely reduce migraine frequency in children and teenagers aged 6-17 years over 12 weeks.
01 Jul 2026 NCT05711394
active not recruiting Phase III
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
Gene-edited stem cell therapy significantly improves severe sickle cell disease in children who cannot tolerate standard treatment.
01 Jul 2026 NCT05329649
active not recruiting Neurology
Validation of a Novel Functional Food Designed to Meet the Nutritional Needs of People Living With Parkinson’s Disease
A 12-week study testing a specially designed drink with added fibre and vitamins to improve constipation and quality of life in Parkinson's disease patients.
01 Jul 2026 NCT06697626
active not recruiting Phase IV Oncology
Effect of Proactive Therapeutic Drug Monitoring on Maintenance of Sustained Disease Control in Adults With Rheumatoid Arthritis on a Subcutaneous TNF Inhibitor: The Rheumatoid Arthritis Therapeutic DRUg Monitoring Trial (RA-DRUM)
Regular blood tests measuring TNF inhibitor levels help maintain disease control better than standard care in rheumatoid arthritis patients.
01 Jul 2026 NCT06440629
active not recruiting Phase III
Open-Label Extension Study of BBP-418 (Ribitol) for LGMD2I/R9
Long-term safety and effectiveness study of oral ribitol for a rare inherited muscle weakness condition in previous trial participants.
01 Jul 2026 NCT07678775
active not recruiting Phase III Oncology
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
Adding abemaciclib to standard hormone therapy may delay cancer progression in men with advanced prostate cancer.
01 Jul 2026 NCT05288166
● Recruiting Phase I Respiratory / COPD / Asthma
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer’s Disease
Drug Being Tested: DNL628 is a novel therapeutic agent undergoing Phase 1b evaluation for safety, tolerability, pharmacokinetics and pharmacodynamics in early Alzheimer's disease using…
01 Jul 2026 NCT07328451
● Recruiting Phase I Neurology
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)
CC-97540, a novel oral immunomodulatory agent, is being evaluated for safety, tolerability, efficacy and pharmacokinetics across three distinct autoimmune neurological conditions: relapsing and progressive…
01 Jul 2026 NCT06220201
● Recruiting Phase II Oncology
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) – Master Screening Protocol
What is being tested: DETERMINE evaluates targeted cancer treatments in rare cancers or common cancers with rare genetic mutations identified through routine molecular testing,…
01 Jul 2026 NCT05722886
● Recruiting Gastroenterology
Adiposity and Iron Requirements in Pregnancy
What is being tested: A double-blind randomized controlled trial investigating whether body fat (adiposity) affects how pregnant women respond to different daily iron supplementation…
01 Jul 2026 NCT06425796
● Recruiting Phase III Rheumatology
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn’s Disease
What is being tested: Duvakitug, a novel therapeutic agent, is undergoing Phase 3 evaluation for induction of remission in moderately to severely active Crohn's…
01 Jul 2026 NCT07184931
● Recruiting Phase II Oncology
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Drug being tested: Ponsegromab (a novel therapeutic agent) combined with standard systemic chemotherapy, compared to chemotherapy alone with placebo, in treatment-naïve patients with metastatic…
01 Jul 2026 NCT06989437
● Recruiting Phase III Oncology
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
Treatment being tested: TDXd (trastuzumab deruxtecan) combined with chemotherapy and pembrolizumab versus standard chemotherapy plus trastuzumab and pembrolizumab as first-line therapy for metastatic HER2-positive…
01 Jul 2026 NCT06731478